Evaluation of 5-Day Vs. 10-Day Decitabine in Combination with Venetoclax in Newly Diagnosed AML Patients Ineligible for Induction Chemotherapy

Authors :: Jorge M. Ramos Perez
Jose Tinajero
Dat Ngo
Jianying Zhang
Paul B. Koller
Vaibhav Agrawal
Hoda Pourhassan
Monzr M. Al Malki
Amandeep Salhotra
Haris Ali
Ahmed Aribi
Karamjeet S. Sandhu
Shukaib Arslan
Salman Otoukesh
Idoroenyi Amanam
Andrew S. Artz
Pamela S. Becker
Forrest M. Stewart
Eileen P. Smith
Peter Curtin
Stephen J Forman
Ryotaro Nakamura
Vinod A. Pullarkat
Guido Marcucci
Anthony S. Stein
Ibrahim Aldoss
Brian J Ball
Source :: Blood. 140:9039-9040
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools